MA28462B1 - FORMULATIONS FOR INHALATION - Google Patents

FORMULATIONS FOR INHALATION

Info

Publication number
MA28462B1
MA28462B1 MA29312A MA29312A MA28462B1 MA 28462 B1 MA28462 B1 MA 28462B1 MA 29312 A MA29312 A MA 29312A MA 29312 A MA29312 A MA 29312A MA 28462 B1 MA28462 B1 MA 28462B1
Authority
MA
Morocco
Prior art keywords
inhalation
formulations
Prior art date
Application number
MA29312A
Other languages
French (fr)
Inventor
Amar Lulla
Geena Malhotra
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of MA28462B1 publication Critical patent/MA28462B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA29312A 2004-03-12 2006-09-08 FORMULATIONS FOR INHALATION MA28462B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN312MU2004 2004-03-12

Publications (1)

Publication Number Publication Date
MA28462B1 true MA28462B1 (en) 2007-03-01

Family

ID=34962995

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29312A MA28462B1 (en) 2004-03-12 2006-09-08 FORMULATIONS FOR INHALATION

Country Status (9)

Country Link
EP (1) EP1732526A2 (en)
JP (1) JP2007528889A (en)
KR (1) KR20060135873A (en)
AP (1) AP2006003734A0 (en)
IL (1) IL177596A0 (en)
MA (1) MA28462B1 (en)
RU (1) RU2006136025A (en)
WO (1) WO2005087192A2 (en)
ZA (1) ZA200606801B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160038767A (en) * 2014-09-30 2016-04-07 한미약품 주식회사 Dry powder for inhalation formulation with improved stability of combined active ingredients

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
IL95590A (en) * 1989-09-08 1996-06-18 Glaxo Group Ltd Pharmaceutical compositions comprising salmeterol and fluticasone propionate
GB2235627B (en) * 1989-09-08 1993-09-01 Glaxo Group Ltd Inhalation medicaments for treating respiratory disorders
ES2206572T3 (en) * 1995-04-14 2004-05-16 Smithkline Beecham Corporation DOSE INHALER MEASURE FOR SALMETEROL.
GB9808802D0 (en) * 1998-04-24 1998-06-24 Glaxo Group Ltd Pharmaceutical formulations
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
NZ538493A (en) * 2002-08-29 2007-10-26 Cipla Ltd Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids

Also Published As

Publication number Publication date
RU2006136025A (en) 2008-04-20
EP1732526A2 (en) 2006-12-20
JP2007528889A (en) 2007-10-18
WO2005087192A2 (en) 2005-09-22
KR20060135873A (en) 2006-12-29
ZA200606801B (en) 2008-05-28
AP2006003734A0 (en) 2006-10-31
IL177596A0 (en) 2006-12-10
WO2005087192A3 (en) 2006-06-15

Similar Documents

Publication Publication Date Title
LTPA2017028I1 (en) Fungicidal compositions
DK1812025T3 (en) STABILIZED BACTERIOPHAGIC FORMULATIONS
IL237756A0 (en) Antibody formulations
BRPI0511900A (en) pharmaceutical compositions
DE602005010938D1 (en) precision casting
DE602005002441D1 (en) Microbicidal composition
DK1750683T3 (en) Prolonged-release formulations
DK1725218T3 (en) Pharmaceutical composition comprising pimobendan
DK1740484T3 (en) Platform
DE202005000407U1 (en) platform
ITMI20042238A1 (en) COMPOUNDS FOR FLUOROPOLIRTEREI
DE502004010641D1 (en) Respirator
GB0423800D0 (en) New pharmaceutical formulations
FR2871686B1 (en) ANTI-DECOLORATION COMPOSITION
ITMI20041447A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING GABAPENTINA
MA28462B1 (en) FORMULATIONS FOR INHALATION
ITMI20040943A1 (en) PHARMACEUTICAL COMPOSITION CICATRIZZANTE
NO20042027D0 (en) Oral composition
ATE384719T1 (en) DIOXAZINYL-SUBSTITUTED THIENYLSULFONYLAMINOCARBONYL COMPOUNDS
FR2872407B1 (en) CORSET FOR LOMBALGIA
AT501354A3 (en) RESPIRATOR
FR2879491B1 (en) SCISSORS FOR CHILDREN
UA11878S (en) INHALER
NO20041954D0 (en) For
NO20043762D0 (en) For